Navigation Links
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture
Date:6/3/2008

to offer a safe and effective, non-surgical treatment for Dupuytren's contracture," said Armando Anido, Auxilium's Chief Executive Officer and President. "We expect the results of these trials, together with all previous clinical and pre-clinical data, will enable us to submit a Biologics License Application for XIAFLEX in Dupuytren's contracture in early 2009. I wish to thank all the patients, investigators and Auxilium employees who contributed to these trials."

CORD I Efficacy Results

CORD I is the largest placebo-controlled study ever conducted in Dupuytren's contracture patients and the second U.S. pivotal phase III study for XIAFLEX in Dupuytren's contracture. A total of 306 patients evaluable for efficacy enrolled in 16 clinical sites across the U.S., with 203 patients receiving XIAFLEX and 103 receiving placebo in the double-blind portion of the study. The joints were stratified 2:1 Metacarpal Phalangeal Joint, or MP joint, to Proximal Intra-Phalangeal, or PIP joint. The primary endpoint was met with 64% (130 of 203) of patients' primary joints treated with XIAFLEX achieving

In addition to the primary endpoint, there were 26 secondary endpoints that were measured, each of which was met with statistical significance. The Company believes two important secondary endpoints are the difference between the pre- and post-treatment contracture angles and whether patients achieved at least a 50% reduction in their contracture compared to baseline. First, the average percent improvement in contracture from baseline was 79.3% (50.2 degrees average contracture at baseline down to 12.2 degrees average contracture after treatment) for primary joints treated with XIAFLEX, compared to placebo patients, where the ave
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
3. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
4. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
5. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
6. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
7. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
8. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
9. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
10. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
11. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ALISO VIEJO, Calif. , Sept. 3, ... a leading global pharmaceutical company, and AqueSys, Inc. ... on developing ocular implants that reduce intraocular pressure ... have entered into an agreement under which Allergan ... the terms of the agreement, Allergan will acquire ...
(Date:9/3/2015)... Research and Markets ... the "Investigation Report on China,s Progesterone Market, ... The clinical demand for steroid drug is increasing ... efficacy especially its extended use in regulating human ... Progesterone, a natural progestogen produced by the ...
(Date:9/3/2015)... DUBLIN , Sep. 03, 2015 ... the addition of the "Investigation Report on China,s ... Developed by Genentech, trastuzumab was approved by FDA ... under the trade name of Herceptin, a major product ... was USD 6.56 billion around the world. After ...
Breaking Medicine Technology:Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 2Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 3Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 4Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 5Allergan to Acquire Glaucoma Treatment Company AqueSys to Add Minimally Invasive Implantable Shunt to Eye Care Offering 6China Progesterone Market Investigation Report 2015-2019 2Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2
... (Nasdaq: CDXS ) today announced the company will ... 2010 at 4:30 p.m. Eastern Time to discuss its third ...  The call and webcast will follow the release of third ... the call will be available approximately one hour after the ...
... Today the Roskamp Institute said that it is pleased ... RCP-006, a compound found in tobacco, for the treatment of ... a subsidiary of Star Scientific in Virginia, and made available ... In laboratory tests with cells, the compound, RCP-006, a ...
Cached Medicine Technology:Roskamp Institute to Begin Human Alzheimer's Clinical Trials With a Natural Compound in Tobacco 2
(Date:9/3/2015)... ... ... TransPack Toon gives users a set of 90 cartoon transitions for ... 30 different styles. Presets range from snow, underwater, forest, futuristic, city and many more. ... 90 cartoon transitions from 30 unique styles. Editors can choose between line and ...
(Date:9/3/2015)... ... September 03, 2015 , ... E-Volve Health, an Elliot ... healthcare solutions organization, to provide electronic medical record (EMR) consulting services to Amerinet ... will receive negotiated pricing on E-Volve Health’s Epic EMR consulting, custom training and ...
(Date:9/3/2015)... ... 03, 2015 , ... DriButts, a non-profit organization dedicated to ... Development Group to manufacture a long-lasting reusable diaper for warm weather climates where ... bring 600 DriButts Diapers to rural areas of Haiti during a trip scheduled ...
(Date:9/3/2015)... (PRWEB) , ... September 03, 2015 , ... ... care community to be situated at 4400 Columbine Drive in Bellingham, Washington. Silverado ... 2016, and has been carefully designed to serve up to 80 people living ...
(Date:9/3/2015)... San Jose, CA (PRWEB) , ... September 03, ... ... high-performance Splashtop remote desktop solution for LANDESK Management Suite customers, as part of ... Management Suite’s user-centered approach to IT, by delivering the best mobile user experience ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios Releases TransPack Toon, a New FCPX Transition 2Health News:E-Volve Health to Offer EMR Consulting Solutions to Amerinet Members 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 2Health News:DriButts Diapers Rely on Slingshot Help in Haiti 3Health News:Site Dedication Ceremony to Celebrate New Silverado Memory Care Community 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4
... just 3 to 5 hours sleep per night, study shows, , , ... teens is getting the recommended eight hours of sleep each night. ... help of highly-caffeinated energy drinks, according to new research. , ... teens polled reported falling asleep in school at least twice ...
... Chemical-Free Cleaning Process Offers Greater than 99.9 Percent Bacterial ... Pro, a convenient hand-held device that offers a breakthrough ... powerful general-purpose cleaner, has now been certified as a ... as directed, the Activeion Pro offers a greater than ...
... a considerable and largely undetected problemSAN FRANCISCO, May ... are away from work significantly longer than other ... by the non-profit Integrated Benefits Institute. The true ... payments and lost productivity -- are 2-1/2 times ...
... Holdings, Inc. (Pink Sheets: NXGH) is pleased to ... Billion Household and Industrial Cleaning Products Industry by ... a company which manufactures and distributes non-toxic, environmentally ... Green Bridge Industries in exchange for a combination ...
... --Data from Ongoing Glioblastoma Dosimetry Trial Accepted for ... Annual Meeting ----Over 65 Recurrent GBM Patients in ... Received Cotara to Date, with a Good Safety ... Calif., May 28 Peregrine Pharmaceuticals, Inc. (Nasdaq: ...
... of Tart Cherries May Help Relieve Post-Exercise Muscle Pain ... ease the pain for people who run, according to ... at the American College of Sports Medicine Conference in ... cherry juice while training for a long distance run ...
Cached Medicine News:Health News:Technology, Caffeine Keeping Teens Awake 2Health News:Technology, Caffeine Keeping Teens Awake 3Health News:Certified Lab Tests Confirm the Activeion Pro Is a Sanitizing Device 2Health News:Certified Lab Tests Confirm the Activeion Pro Is a Sanitizing Device 3Health News:IBI Research Finds Employers Severely Underestimate the Prevalence and Lost Productivity Costs of Depression 2Health News:IBI Research Finds Employers Severely Underestimate the Prevalence and Lost Productivity Costs of Depression 3Health News:NXGen Holdings, Inc. Enters the $17.5 Billion Household and Industrial Cleaning Products Industry through the Acquisition of Green Bridge Industries, Inc. 2Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 2Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 3Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 4Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 5Health News:Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program 6Health News:Is Cherry Juice a New 'Sports Drink?' 2
ACMI™ Distortion-Free Laparoscopes utilize technical advances in optical lens design to provide images without the fish-eye effect typically found on the peripheral viewing edges of conventional...
Stryker autoclavable pediatric laparoscopes provide equivalent brightness and resolution along with the unparalleled durability found in larger laparoscopes....
Inquire...
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
Medicine Products: